DHARTI VAGHELA: Open Payments
NPI 1598129272 · WARREN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49 in 3 payments from 3 companies in 2025. Trend: 2023 $512 · 2024 $484 · 2025 $49
Food & beverage: $49
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Boston Scientific Corporation | 1 | $15 |
Products named: SHINGRIX, XIFAXAN, CDS - MCT/CEM Monitoring.
Industry payments across NJ — which companies pay providers there.
